secwatch.observer — SEC 8-K summary
======================================

Issuer:     OnKure Therapeutics, Inc. (OKUR)
CIK:        0001637715
Form:       8-K
Filed at:   2024-10-02T23:59:59+00:00
Accession:  0001193125-24-231281
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Reneo stockholders approve all proposals for OnKure merger at special meeting
-----------------------------------------------------------------------------

- Proposal 1 (stock issuance for merger) approved: 21.87M for, 110.6K against.
- Proposal 2 (PIPE stock issuance >20%) approved: 21.87M for, 110.7K against.
- Proposal 4 (reverse stock split) approved: 21.85M for, 131.9K against.
- Proposals 5 and 6 (NewCo equity plans) approved by 17.48M and 18.38M votes for.
- All seven proposals passed; adjournment not needed as quorum and votes were sufficient.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1637715/000119312524231281/0001193125-24-231281-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1637715/000119312524231281/d870918d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-231281

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer